Smith & Nephew plc ADR Stock
Smith & Nephew plc ADR Stock
We can see a decrease in the price for Smith & Nephew plc ADR. Compared to yesterday it has lost -€0.600 (-2.140%).
Pros and Cons of Smith & Nephew plc ADR in the next few years
Pros
?
G***** c******* t* c**********
?
M***** P*******
?
C******** o* t** e**********
Cons
?
B****
?
S********** s********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Smith & Nephew plc ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Smith & Nephew plc ADR | -2.140% | -5.517% | -9.868% | 5.385% | -2.143% | 5.385% | -12.739% |
| Smith & Nephew plc | 1.010% | -4.307% | -10.129% | 5.429% | -2.321% | 7.636% | -11.278% |
| Thermo Fisher Scientific Inc. | 1.080% | 0.881% | -5.968% | -13.943% | -16.633% | -19.484% | 7.811% |
| Humana Inc. | -1.880% | -0.846% | -4.715% | -40.496% | -33.288% | -67.678% | -57.164% |
Comments
Smith & Nephew SNATS (NYSE:SNN) was upgraded by analysts at Wall Street Zen from a "buy" rating to a "strong-buy" rating.
Show more
Ratings data for SNN provided by MarketBeat
Smith & Nephew SNATS (NYSE:SNN) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
Show more
Ratings data for SNN provided by MarketBeat
Smith & Nephew plc (NYSE: SNN) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a "buy" rating on the stock.
Show more
Ratings data for SNN provided by MarketBeat
